Dalkon Shield fund plans $1 billion surplus payout:
This article was originally published in Clinica
Executive Summary
With only 6,000 claims still pending, the Dalkon Shield Claimants Trust is projecting a surplus of $1,000 million, which it intends to share among the 49,176 women whose claims for injuries from the contraceptive device have already been settled. The trust was set up in 1989 to resolve 192,000 claims from women believed to have suffered pelvic infections and damage to reproductive organs after using the IUD. Manufacturer AH Robins was sold to American Home Products the same year following bankruptcy court reorganisation.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.